Sugarbaker, P. H., & Stuart, O. A. (2021). Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: Final clinical and pharmacologic data from a phase II protocol and recommended future directions. J Gastrointest Oncol.
Styl cytowania ChicagoSugarbaker, Paul H., i O. Anthony Stuart. "Intraperitoneal Gemcitabine Chemotherapy Is Safe for Patients With Resected Pancreatic Cancer: Final Clinical and Pharmacologic Data From a Phase II Protocol and Recommended Future Directions." J Gastrointest Oncol 2021.
Styl cytowania MLASugarbaker, Paul H., i O. Anthony Stuart. "Intraperitoneal Gemcitabine Chemotherapy Is Safe for Patients With Resected Pancreatic Cancer: Final Clinical and Pharmacologic Data From a Phase II Protocol and Recommended Future Directions." J Gastrointest Oncol 2021.